Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_09fc02a407043ca0a10e2dbe5fcb6159 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-406 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L24-108 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L24-0094 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08L89-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08L77-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08L71-02 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L24-00 |
filingDate |
2011-09-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a01ef292a17d4d6d936c14bfa8a8fbb6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_25e1ad217bc33e8696f3d9114ed211c0 |
publicationDate |
2013-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-2611473-A2 |
titleOfInvention |
Silk fibroin and polyethylene glycol-based biomaterials |
abstract |
This invention relates to methods and compositions for preparation of silk-PEGs based biomaterials through crosslinking by chemically reacting active polyethylene glycols (PEGs) possessing different chemical groups (e.g., thiols and maleimides functionalized PEGs) that are additionally stabilized by the beta-sheet formation of silk fibroin. The crosslinked silk-PEGs biomaterials present strong adhesive properties, which are comparable to or better than the current leading PEG-based sealant, depending on the silk concentration in the silk-PEGs biomaterials. In addition, the silk-PEGs based biomaterials are cytocompatible, show decreased swelling behavior and longer degradation times, which make them suitable for hemostatic applications where the current available tissue sealant products can be contraindicated. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110384823-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110384823-A |
priorityDate |
2010-09-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |